CombiMatrix Corp (CBMX) - Financial and Strategic SWOT Analysis Review
CombiMatrix Corp (CBMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
CombiMatrix Corp (CombiMatrix) is a provider of molecular diagnostic solutions specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It offers DNA-based testing services for the detection of genetic abnormalities. The company provides chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. It provides these molecular diagnostic tests based on its array based technologies including Micro Arrays with single nucleotide polymorphism (SNPs) and Micro Arrays with SNPs for formalin-fixed, paraffin-embedded (FFPE) tissue. CombiMatrix is a CAP approved and CLIA-certified molecular diagnostic laboratory. CombiMatrix is headquartered in Irvine, California, the US.
CombiMatrix Corp Key Recent Developments
May 04,2017: CombiMatrix Reports First Quarter 2017 Financial and Operating Results
Mar 01,2017: CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
Feb 22,2017: CombiMatrix Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
Feb 02,2017: CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board
Jan 20,2017: CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
CombiMatrix Corp (CombiMatrix) is a provider of molecular diagnostic solutions specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It offers DNA-based testing services for the detection of genetic abnormalities. The company provides chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. It provides these molecular diagnostic tests based on its array based technologies including Micro Arrays with single nucleotide polymorphism (SNPs) and Micro Arrays with SNPs for formalin-fixed, paraffin-embedded (FFPE) tissue. CombiMatrix is a CAP approved and CLIA-certified molecular diagnostic laboratory. CombiMatrix is headquartered in Irvine, California, the US.
CombiMatrix Corp Key Recent Developments
May 04,2017: CombiMatrix Reports First Quarter 2017 Financial and Operating Results
Mar 01,2017: CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
Feb 22,2017: CombiMatrix Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
Feb 02,2017: CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board
Jan 20,2017: CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
CombiMatrix Corp - Key Facts
CombiMatrix Corp - Key Employees
CombiMatrix Corp - Key Employee Biographies
CombiMatrix Corp - Major Products and Services
CombiMatrix Corp - History
CombiMatrix Corp - Company Statement
CombiMatrix Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
CombiMatrix Corp - Business Description
CombiMatrix Corp - SWOT Analysis
SWOT Analysis - Overview
CombiMatrix Corp - Strengths
CombiMatrix Corp - Weaknesses
CombiMatrix Corp - Opportunities
CombiMatrix Corp - Threats
CombiMatrix Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
CombiMatrix Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017
CombiMatrix Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 04, 2017: CombiMatrix Reports First Quarter 2017 Financial and Operating Results
Mar 01, 2017: CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
Feb 22, 2017: CombiMatrix Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
Feb 02, 2017: CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board
Jan 20, 2017: CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss
Nov 02, 2016: CombiMatrix Reports Third Quarter 2016 Financial and Operating Results
Aug 03, 2016: CombiMatrix Reports Second Quarter 2016 Financial and Operating Results
Jun 01, 2016: CombiMatrix Launches Next Generation Sequencing for Pre-Implementation Genetic Screening
May 04, 2016: CombiMatrix Reports First Quarter 2016 Financial and Operating Results
Apr 21, 2016: CombiMatrix Provides Strategic Update
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
CombiMatrix Corp - Key Facts
CombiMatrix Corp - Key Employees
CombiMatrix Corp - Key Employee Biographies
CombiMatrix Corp - Major Products and Services
CombiMatrix Corp - History
CombiMatrix Corp - Company Statement
CombiMatrix Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
CombiMatrix Corp - Business Description
CombiMatrix Corp - SWOT Analysis
SWOT Analysis - Overview
CombiMatrix Corp - Strengths
CombiMatrix Corp - Weaknesses
CombiMatrix Corp - Opportunities
CombiMatrix Corp - Threats
CombiMatrix Corp - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
CombiMatrix Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017
CombiMatrix Corp, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
May 04, 2017: CombiMatrix Reports First Quarter 2017 Financial and Operating Results
Mar 01, 2017: CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
Feb 22, 2017: CombiMatrix Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
Feb 02, 2017: CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board
Jan 20, 2017: CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss
Nov 02, 2016: CombiMatrix Reports Third Quarter 2016 Financial and Operating Results
Aug 03, 2016: CombiMatrix Reports Second Quarter 2016 Financial and Operating Results
Jun 01, 2016: CombiMatrix Launches Next Generation Sequencing for Pre-Implementation Genetic Screening
May 04, 2016: CombiMatrix Reports First Quarter 2016 Financial and Operating Results
Apr 21, 2016: CombiMatrix Provides Strategic Update
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
CombiMatrix Corp, Key Facts
CombiMatrix Corp, Key Employees
CombiMatrix Corp, Key Employee Biographies
CombiMatrix Corp, Major Products and Services
CombiMatrix Corp, History
CombiMatrix Corp, Subsidiaries
CombiMatrix Corp, Key Competitors
CombiMatrix Corp, Ratios based on current share price
CombiMatrix Corp, Annual Ratios
CombiMatrix Corp, Annual Ratios (Cont.1)
CombiMatrix Corp, Interim Ratios
CombiMatrix Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017
CombiMatrix Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
CombiMatrix Corp, Key Facts
CombiMatrix Corp, Key Employees
CombiMatrix Corp, Key Employee Biographies
CombiMatrix Corp, Major Products and Services
CombiMatrix Corp, History
CombiMatrix Corp, Subsidiaries
CombiMatrix Corp, Key Competitors
CombiMatrix Corp, Ratios based on current share price
CombiMatrix Corp, Annual Ratios
CombiMatrix Corp, Annual Ratios (Cont.1)
CombiMatrix Corp, Interim Ratios
CombiMatrix Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017
CombiMatrix Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
CombiMatrix Corp, Performance Chart (2012 - 2016)
CombiMatrix Corp, Ratio Charts
CombiMatrix Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017
COMPANIES MENTIONED
Quest Diagnostics Inc
Progenity Inc
Natera Inc
Life Technologies Corp
Laboratory Corp of America Holdings
CombiMatrix Corp, Performance Chart (2012 - 2016)
CombiMatrix Corp, Ratio Charts
CombiMatrix Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017
COMPANIES MENTIONED
Quest Diagnostics Inc
Progenity Inc
Natera Inc
Life Technologies Corp
Laboratory Corp of America Holdings